Analysis of long-term survival in patients with locally advanced non-small cell lung cancer

Oncology Reports

Volumn 5, Issue 6, 1998, Pages 1547-1550

  Wagner, Wolfgang ^a   Striehn, Eberhard ^b   Klinke, Folker ^b   Bosse, Ulrich ^b   Rübe, Christian ^c  

^a Paracelsus Klinik Osnabruck   (Germany)

^b St Elisabeth Hospital   (Germany)

^c UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Advanced NSCLC; Inultimodal therapy; Mediastinal lymph nodes; Prognostic factors; Quantitative analysis; Survival

Indexed keywords

CARBOPLATIN; ETOPOSIDE; IFOSFAMIDE; VINDESINE;

ADJUVANT CHEMOTHERAPY; ADULT; ADVANCED CANCER; AGED; ANALYTIC METHOD; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; DRUG EFFECT; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM LYMPH NODE; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CARCINOMA, NON-SMALL-CELL LUNG; COMBINED MODALITY THERAPY; ETOPOSIDE; FEMALE; FOLLOW-UP STUDIES; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; IFOSFAMIDE; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROBABILITY; RADIOTHERAPY; SURVIVAL RATE; SURVIVORS; VINDESINE;

EID: 0031719237     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.5.6.1547     Document Type: Article

References (37)

1. Emai B and Perez CA: Lung. In: Principles and Practice of Radiation Oncology. 2nd edition. Perez CA and Brady LW (eds). Lippincott. Philadelphia, pp806-837, 1992.
2. Wagner W, von Eiff M, Klinke F, Micke O, Rübe C and Willich N: Neoadjuvante Radiochemotherapie beim lokal fortgeschrittenen nichtkleinzelligen Bronchialkarzinom: Erste Ergebnisse einer multizentrischen prospektiven Studie. Strahlenther Onkol 171:390-397, 1995.
3. Thomas M, Rübe C, Semik M, Junker K and von Eiff M: Neoadjuvante multimodale therapie im stadium IIIA des nichtkleinzellisen Bronchialkarzinoms. Dtsch Med Wochenschr 122: 993-998, 1997.
4. Belani CP and Aisner J: Combined modality therapies for non-small cell lung cancer. Ann Oncol 3: 3-10, 1992.
5. Dunst J and Sauer R: Simultane Radiochemotherapie. Strahlentherapie. Strahlenther Oncol 169: 205-212, 1993.
6. Kaasa S, Thorud E, Host H, Lien HH, Lund E and Sjolie I: A randomized study evaluating radiotherapy versus chemotherapy in patients with inoperable non-small cell lung cancer. Radiother Oncol 11:7-13, 1988.
7. Nasr E, Pellae-Cosset B, Arriagada R, Le Chevalier T, Baldeyrou P, Ruffle P, de Cremoux, Martin M and Taraye M: Combination of chemotherapy (vindesine. Iomustine, cisplatin, cyclophasphamide) and thoracic radiotherapy in nonresectable non-small cell bronchial carcinoma: Final results of a phase II clinical trial. Bull Cancer Paris 79: 1039-1043, 1992.
8. Perez CA, Pajak TF, Rubin P, Simpson JR, Mohiudin M, Brady LW, Perez-Tamoya R and Rotman M: Long term observation of the pattern of failure in patients with unresectable non-oat cell carcinoma of the lung treated with definitive radiotherapy. Cancer 59: 1874-1881, 1987.
9. Petrovich Z, Stanley K, Cox JD and Paig C: Radiotherapy in the management of locally advanced lung cancer of all cell types. Cancer 48: 1335-1340, 1981.
10. Bunn PA: The treatment of non-small cell lung cancer. Current perspective and controversis, future directions. Semin Oncol 21 (Suppl 6): 49-59, 1994.
11. Martini N and Flehinger BJ: The role of surgery in N2 lung cancer. Surg Clin North Amer 7: 1037-1049, 1987.
12. Albain KS: Induction therapy followed by definitive local control for stage III non-small cell lung cancer. A review, with a focus on recent trimodality trials. Chest 102: 43-50, 1993.
13. Choi NCH and Doucette JA: Improved survival of patients with unresectable non-small bronchogenic carcinoma by an innovated high-dose en-bloc radiotherapeutic approach. Cancer 48, 101-109, 1981.
14. Dillmann RO, Seagren SL, Propert KJ, Guerra J, Eaton WL, Perry MC, Carey RW, Frei EF and Green MR: A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small cell lung cancer. N Engl J Med 323: 940-945, 1990.
15. Fowler WC, Langer CJ, Curran WJ and Keller SM: Postoperative complications after combined neoadjuvant treatment of lung cancer. Ann Thorac Surg 55: 986-989, 1993.
16. Havemann K, Wolf M, Görg E, Hackenbruch R, Pfab K and Görg K: Preclinical and clinical experience with cisplatin and carboplatin and simultaneous radiation on non-small cell lung cancer. Ann Oncol 3: 23-27, 1992.
17. Martini N, Kris MG, Flehinger BJ, Gralla RJ, Bains MS, Burt ME, Heelan R, McCormack PM, Pisters KM and Rigas JR: Preoperative chemotherapy for stage III a (N2) lung cancer: The Sloan Kettering experience with 136 patients. Ann Thorac Surg 55: 1365-1373, 1993.
18. Niitamo-Korhonen SP, Holsti P, Holsti LR, Pyrhonen S and Mattson K: A comparison of cis-plantinum-vindesine and cis-platinum-etoposide combined with radiotherapy for previously untreated localized inoperable non-small cell lung cancer. Eur J Cancer Clin Oncol 25: 1039-1043, 1989.
19. Pincus M, Reddy S, Lee MS, Bonomi P, Tylor IVS, Rowland K, Faber LP, Warren W, Kittle CF and Hendrickson FR: Preoperative combined modality therapy for stage III Mo non-small cell lung carcinoma. Int J Radiat Oncol Biol Phys 15: 189-195, 1988.
20. Pujol JL, Rossi JF, Le Chevalier T, Daures JP, Rouanet P, Douillard JY, Dubois JB, Arriagada R, Mary H and Godard P: Pilot study of neoadjuvant ifosfamide. cisplatin and etoposide in locally advanced non-small cell lung cancer. Eur J Cancer 26: 798-801, 1990.
21. Rossel R, Moreno I, Maestre J, Olazabal A, Carles J, Barnadas A, Abad-Esteve A, Ribelles N and Canela M: Cyclophosphamide and ifosfamide combination as neoadjuvant chemotherapy for locally advanced non-small cell lung cancer: a meta-analytic review. J Surg Oncol 45: 124-130, 1990.
22. Schaake-Koning C, Schuster-Uitterhoeve L, Hart G and Gonzales-Gonzalez D: Prognostic factors of inoperable localized lung cancer treated by high dose radiotherapy. Int J Radiat Oncol Biol Phys 9: 1023-1028, 1983.
23. Schaake-Koning C, Maat B, van Houtte P, van den Bogaert W, Dalesio O, Kirkpatrick JA, Koolen M and Bartelink H: Radiotherapy combined with low-dose cis-diminedichloroplatinum (II) (CDDP) in inoperable nonmetastatic non-small cell lung cancer (NSCLC): a randomized three arm phase II study of EORTC lung cancer and radiotherapy cooperative groups. Int J Radiat Oncol Biol Phys 19: 967-972, 1990.
24. Schaake-Koning C, van den Bogaert W, Dalesio O, Festen J, Hoogenhout J, van Houtte P, Kirkpatrick A, Koolen M, Maat B, Nijs A, Renaud A, Rodigus P, Schuster-Uitterhoeve L, Sculier JP, van Zandwijk N and Bartelink H: Effects of concomitant cisplatin and radiotherapy on inoperable non-small cell lung cancer. N Engl J Med 326: 530-542, 1992.
25. Shepherd FA: Induction chemotherapy for locally advanced non-small cell lung cancer. Ann Thorac surg 55: 1585-1592, 1993.
26. Yokes EE, Bitran JD, Hoffmann PC, Ferguson MK, Weichselbaum RR and Golomb HM: Neoadjuvant vindesine, etoposide and cisplatin for locally advanced non-small cell lung cancer. Final report of a phase 2 study. Chest 96: 110-113, 1989.
27. Johnson DH, Strupp J, Greco FA, Stewart J, Merril W, Malcom A, Hande KR and Hainsworth JD: Neoadjuvant cisplatin plus vinblastine chemotherapy in locally advanced non-small cell lung cancer. Cancer 68: 1216-1220, 1991.
28. Dillmann RO, Herndon J, Seagren SL, Eaton WL Jr and Green MR: Improved survival in stage III non-small cell lung cancer: seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial. J Natl Cancer Inst 88: 1210-1215, 1996.
29. Le Chevalier T, Arriagada R, Quoix E, et al: Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small cell lung cancer: first analysis of randomized trial in 353 patients. J Natl Cancer Inst 83: 417-423, 1991.
30. Rossel R, Gomze-Codina J, Campe C, et al: A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small cell lung cancer. N Engl J Med 330: 153-158, 1994.
31. Sause WT, Scott C, Taylor S, et al: Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: Preliminaray results of a phase III trial in regionally advanced, unresectable non-small cell lung cancer. J Natl Cancer Inst 87: 198-205, 1995.
32. UICC, Internation Union Against Cancer. TMN Klassifikation malginer Tumoren. Springer, Berlin, 1987.
33. Kaplan EL and Meier P: Non-parametic estimation from incomplete observations. J Am Stat Assoc 53: 457-481, 1958.
34. Salzer-Kuntschik M, Brand G and Delling G: Bestimmung des morphologischen Regressionsgrades nach Chemotherapie bei malignen Knochentumoren. Pathologe 4: 125-141, 1983.
35. Manegold C, Schirren J, Schneider P, Drings P, Vogt-Moykopf I, Schraube and Wannenmacher M: Gegenwärtiger Stand der interdisziplinären Therapie des Stadium III des nicht-kleinzelligen Bronchialkarzinoms. Pneumologie 505: 735-741, 1986.
36. Albain KS, Rusch VW, Crowley JJ, Rice TW, Turrisis AT, Weick JK, Lonchyna VA, Presant CA, McKenna RJ, Gandara DR, Fosmire H, Taylor SA, Stelzer KJ, Beasley KR and Livingston RB: Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages III A (N2) and IIB non-small cell lung cancer. Mature results of Southwest Oncology Group phase II stude 8805. J Clin Oncol 3: 1880-1892, 1995.
37. Choi NC, Carey RW, Daly W, Mathisen D, Wain J, Wright C, Lynch T, Grossbord M and Grille H: Potential impact on survival of improved tumor downstaging and resection rate by preoperative twice daily radiation and concurrent chemotherapy in stage IIIa non-small cell lung cancer. J Clin Oncol 15: 712-722, 1997.